Learn more about Activase® (Alteplase) for Acute Ischemic Stroke Treatment. Indications
Activase (alteplase) is indicated for the treatment of acute ischemic stroke. Exclude intracranial hemorrhage as the primary cause of stroke signs and symptoms prior t
Acute Ischemic Stroke Indication: Activase is indicated for the management of acute ischemic stroke in adults for improving neurological recovery and reducing the incidence of disability. Treatment should only be initiated within 3 hours after the onset o
Acute Ischemic Stroke Indication: Activase is indicated for the management of acute ischemic stroke in adults for improving neurological recovery and reducing the incidence of disability. Treatment should only be initiated within 3 hours after the onset o
Acute Ischemic Stroke Indication: Activase is indicated for the management of acute ischemic stroke in adults for improving neurological recovery and reducing the incidence of disability. Treatment should only be initiated within 3 hours after the onset o
Learn more about Cathflo® Activase® (alteplase), the only lytic FDA-approved for restoring CVAD function for patients with occluded catheters. Cathflo® Activase® (Alteplase) is indicated for the restoration of function to central venous ac
Acute Ischemic Stroke Indication: Activase is indicated for the management of acute ischemic stroke in adults for improving neurological recovery and reducing the incidence of disability. Treatment should only be initiated within 3 hours after the onset o
Learn more about Cathflo® Activase® (alteplase), the only lytic FDA-approved for restoring CVAD function for patients with occluded catheters. Cathflo® Activase® (Alteplase) is indicated for the restoration of function to central venous ac
Acute Ischemic Stroke Indication: Activase is indicated for the management of acute ischemic stroke in adults for improving neurological recovery and reducing the incidence of disability. Treatment should only be initiated within 3 hours after the onset o
Acute Ischemic Stroke Indication: Activase is indicated for the management of acute ischemic stroke in adults for improving neurological recovery and reducing the incidence of disability. Treatment should only be initiated within 3 hours after the onset o
Acute Ischemic Stroke Indication: Activase is indicated for the management of acute ischemic stroke in adults for improving neurological recovery and reducing the incidence of disability. Treatment should only be initiated within 3 hours after the onset o
Learn more about Cathflo® Activase® (alteplase), the only lytic FDA-approved for restoring CVAD function for patients with occluded catheters. Cathflo® Activase® (Alteplase) is indicated for the restoration of function to central venous ac
Learn more about Cathflo® Activase® (alteplase), the only lytic FDA-approved for restoring CVAD function for patients with occluded catheters. Cathflo® Activase® (Alteplase) is indicated for the restoration of function to central venous ac
Acute Ischemic Stroke Indication: Activase is indicated for the management of acute ischemic stroke in adults for improving neurological recovery and reducing the incidence of disability. Treatment should only be initiated within 3 hours after the onset o
Acute Ischemic Stroke Indication: Activase is indicated for the management of acute ischemic stroke in adults for improving neurological recovery and reducing the incidence of disability. Treatment should only be initiated within 3 hours after the onset o
Acute Ischemic Stroke Indication: Activase is indicated for the management of acute ischemic stroke in adults for improving neurological recovery and reducing the incidence of disability. Treatment should only be initiated within 3 hours after the onset o
Learn more about Cathflo® Activase® (alteplase), the only lytic FDA-approved for restoring CVAD function for patients with occluded catheters. Cathflo® Activase® (Alteplase) is indicated for the restoration of function to central venous ac
Learn more about Cathflo® Activase® (alteplase), the only lytic FDA-approved for restoring CVAD function for patients with occluded catheters. Cathflo® Activase® (Alteplase) is indicated for the restoration of function to central venous ac
Acute Ischemic Stroke Indication: Activase is indicated for the management of acute ischemic stroke in adults for improving neurological recovery and reducing the incidence of disability. Treatment should only be initiated within 3 hours after the onset o
Acute Ischemic Stroke Indication: Activase is indicated for the management of acute ischemic stroke in adults for improving neurological recovery and reducing the incidence of disability. Treatment should only be initiated within 3 hours after the onset o
Learn more about Cathflo® Activase® (alteplase), the only lytic FDA-approved for restoring CVAD function for patients with occluded catheters. Cathflo® Activase® (Alteplase) is indicated for the restoration of function to central venous ac
Learn more about Cathflo® Activase® (alteplase), the only lytic FDA-approved for restoring CVAD function for patients with occluded catheters. Cathflo® Activase® (Alteplase) is indicated for the restoration of function to central venous ac
Acute Ischemic Stroke Indication: Activase is indicated for the management of acute ischemic stroke in adults for improving neurological recovery and reducing the incidence of disability. Treatment should only be initiated within 3 hours after the onset o
Learn more about Cathflo® Activase® (alteplase), the only lytic FDA-approved for restoring CVAD function for patients with occluded catheters. Cathflo® Activase® (Alteplase) is indicated for the restoration of function to central venous ac
Learn more about Cathflo® Activase® (alteplase), the only lytic FDA-approved for restoring CVAD function for patients with occluded catheters. Cathflo® Activase® (Alteplase) is indicated for the restoration of function to central venous ac
Acute Ischemic Stroke Indication: Activase is indicated for the management of acute ischemic stroke in adults for improving neurological recovery and reducing the incidence of disability. Treatment should only be initiated within 3 hours after the onset o
Acute Ischemic Stroke Indication: Activase is indicated for the management of acute ischemic stroke in adults for improving neurological recovery and reducing the incidence of disability. Treatment should only be initiated within 3 hours after the onset o
Learn more about Cathflo® Activase® (alteplase), the only lytic FDA-approved for restoring CVAD function for patients with occluded catheters. Cathflo® Activase® (Alteplase) is indicated for the restoration of function to central venous ac
Learn more about Cathflo® Activase® (alteplase), the only lytic FDA-approved for restoring CVAD function for patients with occluded catheters. Cathflo® Activase® (Alteplase) is indicated for the restoration of function to central venous ac
Acute Ischemic Stroke Indication: Activase is indicated for the management of acute ischemic stroke in adults for improving neurological recovery and reducing the incidence of disability. Treatment should only be initiated within 3 hours after the onset o
Acute Ischemic Stroke Indication: Activase is indicated for the management of acute ischemic stroke in adults for improving neurological recovery and reducing the incidence of disability. Treatment should only be initiated within 3 hours after the onset o